Key Takeaways
- FuturaGene obtains regulatory approval from Brazil’s CTNBio for gene-edited eucalyptus
- Variety qualifies for exemption under Normative Resolution No. 16 (RN 16)
- Developed using CRISPR-Cas9 without introducing foreign genetic material
- Modification aims to improve wood quality and reduce pulping inputs
- Controlled field trials to proceed under regulatory compliance in Brazil
FuturaGene Secures Regulatory Clearance for Gene-Edited Eucalyptus
FuturaGene, the biotechnology subsidiary of Suzano, has received formal approval from Brazil’s National Biosafety Technical Commission (CTNBio) for a new gene-edited eucalyptus variety. CTNBio confirmed that the variety meets the exemption criteria outlined under Normative Resolution No. 16 (RN 16).
The new variety was developed using CRISPR-Cas9, a gene-editing technique categorized as a New Breeding Technique (NBT). According to the company, the process does not introduce genetic material from other species, and the resulting modification is comparable to variations that may occur naturally or through conventional breeding.
Focus on Wood Quality and Industrial Efficiency
The gene edit is designed to optimize lignin composition within the wood. By modifying lignin characteristics, the development aims to support more efficient industrial processing by reducing chemical inputs and energy consumption during pulping operations.
Following regulatory clearance, FuturaGene will conduct controlled field trials across multiple growing environments in Brazil. The company stated that trials will adhere to established biosafety and governance standards in full compliance with regulatory requirements.
FuturaGene Expands Biotechnology Portfolio
FuturaGene has previously received 11 CTNBio approvals for genetically modified eucalyptus varieties with traits including yield enhancement, herbicide tolerance, and insect resistance. This approval marks the company’s first authorization for a gene-edited eucalyptus product.
According to FuturaGene, the introduction of gene-editing technology expands its biotechnology toolkit, complementing its existing genetically modified portfolio. The company stated that these innovations are intended to support sustainable production of bio-based materials while addressing climate variability and resource constraints in commercial forestry.
